These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27402593)

  • 1. Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules.
    Morita D; Sugita M
    Immunology; 2016 Oct; 149(2):139-45. PubMed ID: 27402593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Structure of an MHC Class I-Encoded Protein with the Potential to Present
    Yamamoto Y; Morita D; Shima Y; Midorikawa A; Mizutani T; Suzuki J; Mori N; Shiina T; Inoko H; Tanaka Y; Mikami B; Sugita M
    J Immunol; 2019 Jun; 202(12):3349-3358. PubMed ID: 31043477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex.
    Morita D; Yamamoto Y; Mizutani T; Ishikawa T; Suzuki J; Igarashi T; Mori N; Shiina T; Inoko H; Fujita H; Iwai K; Tanaka Y; Mikami B; Sugita M
    Nat Commun; 2016 Jan; 7():10356. PubMed ID: 26758274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the ternary complex of TCR, MHC class I and lipopeptides.
    Morita D; Iwashita C; Mizutani T; Mori N; Mikami B; Sugita M
    Int Immunol; 2020 Nov; 32(12):805-810. PubMed ID: 32720986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of lysophospholipid-bound MHC class I molecules.
    Shima Y; Morita D; Mizutani T; Mori N; Mikami B; Sugita M
    J Biol Chem; 2020 May; 295(20):6983-6991. PubMed ID: 32269076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding.
    Asa M; Morita D; Kuroha J; Mizutani T; Mori N; Mikami B; Sugita M
    J Biol Chem; 2022 Jul; 298(7):102100. PubMed ID: 35667438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular requirements for T cell recognition of N-myristoylated peptides derived from the simian immunodeficiency virus Nef protein.
    Morita D; Yamamoto Y; Suzuki J; Mori N; Igarashi T; Sugita M
    J Virol; 2013 Jan; 87(1):482-8. PubMed ID: 23097434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen Alleles.
    Yao S; Liu J; Qi J; Chen R; Zhang N; Liu Y; Wang J; Wu Y; Gao GF; Xia C
    J Immunol; 2016 Feb; 196(4):1943-54. PubMed ID: 26764037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Definition of Duck Major Histocompatibility Complex Class I Molecules That Might Explain Efficient Cytotoxic T Lymphocyte Immunity to Influenza A Virus.
    Wu Y; Wang J; Fan S; Chen R; Liu Y; Zhang J; Yuan H; Liang R; Zhang N; Xia C
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28490583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral interference with MHC class I antigen presentation pathway: the battle continues.
    Ambagala AP; Solheim JC; Srikumaran S
    Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo.
    Haurum JS; Høier IB; Arsequell G; Neisig A; Valencia G; Zeuthen J; Neefjes J; Elliott T
    J Exp Med; 1999 Jul; 190(1):145-50. PubMed ID: 10429679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
    Zhou X; Abdel Motal UM; Berg L; Jondal M
    Eur J Immunol; 1992 Dec; 22(12):3085-90. PubMed ID: 1446701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ; Crotty S; Andino R; Rock KL
    Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.
    Albert ML; Sauter B; Bhardwaj N
    Nature; 1998 Mar; 392(6671):86-9. PubMed ID: 9510252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation in virus infection.
    Murray N; McMichael A
    Curr Opin Immunol; 1992 Aug; 4(4):401-7. PubMed ID: 1388841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of bovine MHC class I allele-specific peptide motifs and proteolytic cleavage specificities for the prediction of potential cytotoxic T lymphocyte epitopes of bovine viral diarrhea virus.
    Hegde NR; Srikumaran S
    Virus Genes; 1997; 14(2):111-21. PubMed ID: 9237350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viral strategies of interference with MHC functions].
    Ishido S; Goto E; Sato Y; Hotta H
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2145-51. PubMed ID: 12518428
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.